USPTO serial 88332411
ALERACARE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEE, REBECCA ANN
- Law office
- TMO LAW OFFICE 122
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALERACARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Medical referrals; managed care services, namely, electronic processing of health care and pharmaceutical information; procurement, namely, purchasing pharmaceuticals for others; supplying prescription drugs to health plan participants for the funding organizations | ACTIVE | — |
| 041 | Medical educational services, namely, providing courses of instruction in the medical fields of parenteral and enteral therapy and intraperitoneal therapy and treatment; medical education services namely, training for medical professionals and patients regarding the use and application of enteral and parenteral therapy for medical purposes and distributing course materials in connection therewith; medical educational services, namely, providing individualized and group instruction, seminars and workshops for patients and caregivers of patients requiring parenteral and enteral therapy for medical purposes | ACTIVE | — |
| 042 | Providing medical and scientific compounding laboratory services to pharmaceutical manufacturers for new drug applications | ACTIVE | — |
| 044 | Medical services, namely, providing therapy management services relating to the provision of ambulatory infusion therapies and home infusion therapies; Medical provider services, namely, infusion services and injection of pharmaceuticals provided at home and in clinics; nursing services at home and in clinics; Specialty and compounding pharmacy services, namely, dispensing pharmaceuticals, and providing managed health care services in the nature of pharmaceutical and therapy management services to patients, managed care organizations and providers; sterile and non-sterile compounding of pharmaceuticals; Providing medical services in the fields of oncology, hepatitis, Crohn's, immune deficiency, pulmonary, multiple sclerosis, rheumatoid arthritis, interferon, fertility, growth hormone, anti-infectives, hemophilia, osteoarthritis, steroid, hormone replacement, veterinary, respiratory, wound care, transplant, alcohol and opiate dependency, dermatological and nutrition therapy services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AleraCare Holdings, LLC
- Other trademarks owned by AleraCare Holdings, LLC
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALERACARE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 26, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 22, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 20, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 20, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 20, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 20, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 20, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 24, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 20, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 20, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 20, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 22, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 20, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 20, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 20, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 2, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 1, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 1, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 24, 2022 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jan 23, 2022 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jan 23, 2022 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jan 23, 2022 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jan 20, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 20, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 25, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 25, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 5, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 21, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 21, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 8, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 8, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 8, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 22, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 21, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 21, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 21, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 27, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 12, 2019 | NWAP | NEW APPLICATION ENTERED | — |